Nesivine Pediatrie Sine Conservans (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride, the active ingredient in Nesivine Sine Conservans, is an alpha-adrenergic agonist presented as a nasal spray for topical nasal use. It relieves nasal congestion associated with the common cold, allergic rhinitis and sinusitis in children. GNH USA supplies Nesivine Sine Conservans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxymetazoline is a topical nasal decongestant that acts on the vascular component of upper‑respiratory inflammation. - Common cold: provides temporary relief of nasal blockage by reducing mucosal swelling. - Allergic rhinitis: eases congestion and improves airflow during allergic episodes. - Sinusitis: helps diminish nasal obstruction linked to acute sinus inflammation.

Nesivine Sine Conservans may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation - Burning sensation in the nose - Dryness of nasal passages - Sneezing

Serious or Rare Side Effects: - Hypertension - Rebound nasal congestion (rhinitis medicamentosa) - Severe allergic reaction, including anaphylaxis

Before using this nasal spray, consider the following safety measures. - Age restriction: not recommended for children under 6 years unless directed by a physician. - Duration of use: limit to three consecutive days to avoid rebound congestion. - Cardiovascular disease: use with caution and monitor blood pressure. - Pregnancy and lactation: consult a healthcare professional before use. - Drug interactions: avoid concomitant use with other nasal decongestants or MAO inhibitors. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Oxymetazoline may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Concurrent use of other topical nasal decongestants: may cause excessive vasoconstriction and rebound congestion.

Moderate Interactions (Monitor Closely): - Systemic sympathomimetic agents (e.g., pseudoephedrine): may amplify cardiovascular effects. - Beta‑blockers: may blunt compensatory tachycardia. - Antihypertensive medications: monitor blood pressure for unexpected changes.